1. Home
  2. VTRS vs BEKE Comparison

VTRS vs BEKE Comparison

Compare VTRS & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

SELL

Current Price

$17.56

Market Cap

18.7B

Sector

Health Care

ML Signal

SELL

Logo KE Holdings Inc (each representing three)

BEKE

KE Holdings Inc (each representing three)

BUY

Current Price

$16.83

Market Cap

17.4B

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
VTRS
BEKE
Founded
1961
2001
Country
United States
China
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
17.4B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
VTRS
BEKE
Price
$17.56
$16.83
Analyst Decision
Buy
Strong Buy
Analyst Count
12
22
Target Price
$19.40
★ $23.82
AVG Volume (30 Days)
★ 7.3M
4.8M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
★ 2.72%
1.67%
EPS Growth
N/A
★ N/A
EPS
★ 0.05
N/A
Revenue
★ $14,299,900,000.00
N/A
Revenue This Year
$3.42
N/A
Revenue Next Year
$1.68
$4.47
P/E Ratio
$351.50
★ $41.26
Revenue Growth
N/A
★ N/A
52 Week Low
$9.69
$13.81
52 Week High
$18.43
$19.88

Technical Indicators

Market Signals
Indicator
VTRS
BEKE
Relative Strength Index (RSI) 56.26 50.74
Support Level $15.94 $16.73
Resistance Level $18.23 $17.63
Average True Range (ATR) 0.47 0.32
MACD 0.03 0.04
Stochastic Oscillator 50.14 77.73

Price Performance

Historical Comparison
VTRS
BEKE

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2025, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.

Share on Social Networks: